Atazanavir Sulfate

Product NDC
60687-399
11-digit product format
606870399
Labeler code
60687
Product ID
60687-399_86549ef5-0809-3c5a-e053-2991aa0a16d3
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Atazanavir
Dosage form
CAPSULE
Route
ORAL
Labeler
American Health Packaging
Application
ANDA204806
Marketing category
ANDA
Marketing start
2018-09-12
Marketing end
2020-05-31
Substance
ATAZANAVIR SULFATE
Active strength
300 mg/1
Pharmacologic classes
HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60687-399-25EA - Each60687-3995e8d664e-bbb8-495c-9a68-a0cbd88ddf5012018-10-11
60687-399-95EA - Each60687-399768a77b1-5e98-47db-89b6-715c1c7fd82912018-10-11